20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T62856 | FFA1 agonist-1 | ||
FFA1 agonist-1 (Compound 17a) is an orally active fatty acid receptor (FFA1) agonist (EC50: 0.75 μM). | |||
TQ0020 | AMG 837 calcium hydrate | GPR | |
AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM. AMG 837 calcium hydrate also shows highly selective over GPR41, GPR43, and GPR120 (EC50 > 10,000 nM). | |||
T3171 | GSK137647A | GSK 137647 | GPR |
GSK137647A (GSK 137647) is a selective FFA4 agonist. | |||
T1781 | GW9508 | GW 9508 | GPR , Potassium Channel |
GW9508(GW 9508) is a potent and selective agonist for FFA1 (GPR40), stimulates insulin secretion in a glucose-sensitive manner. | |||
T17177 | TUG-424 | TUG424 | Others |
TUG-424 significantly enhances glucose-stimulated insulin secretion at 100 nM. TUG-424 is a potent and selective free fatty acid receptor 1 agonist (EC50: 32 nM). | |||
T7127 | DC260126 | Apoptosis , GPR | |
DC260126 is a small-molecule antagonist of FFA1 (GPR40) | |||
T22967 | MEDICA16 | MEDICA 16 | GPR , Others , ATP Citrate Lyase |
MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120. MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle with an increase in insu... | |||
T15810 | LY2922470 | GPR | |
LY2922470 reduces glucose levels along with significant enhancements in insulin and GLP-1, which is the potential for the treatment of type 2 diabetes mellitus (T2DM). LY2922470 is an effective, selective, and orally ava... | |||
T14200 | AM-1638 | GPR | |
AM-1638 is a full agonist of GPR40/FFA1 (EC50: 0.16 μM). | |||
TQ0241 | TUG-770 | GPR | |
TUG-770 is a highly potent agonist of free fatty acid receptor 1 (FFA1/GPR40, EC50: 6 nM for hFFA1). | |||
T2351 | Fasiglifam | TAK875 | GPR |
Fasiglifam (TAK875) is a potent, selective and orally bioavailable GPR40 agonist. | |||
T62848 | AMG 837 hemicalcium | ||
AMG 837 hemicalcium is a potent, orally active GPR40/FFA1 partial agonist. AMG 837 hemicalcium inhibits the specific binding of [3H]AMG 837 to the human FFA1 receptor (pIC50: 8.13). insulin secretion and reduced glucose ... | |||
T11583 | HWL-088 | Others | |
HWL-088 is a potent free fatty acid receptor 1 (FFA1/GPR40) agonist. HWL-088 significantly improves glucose tolerance in normal and diabetic models. | |||
T35816 | ZLY032 | ||
ZLY032 is a dual agonist of free fatty acid receptor 1 (FFAR1/GPR40; EC50= 68 nM in a FLIPR assay) and peroxisome proliferator-activated receptor δ (PPARδ; EC50= 102 nM in a reporter assay).1It is selective for FFAR1 and... | |||
T15448 | GW-1100 | GPR | |
GW-1100 is a selective antagonist of GPR40 (pIC50: 6.9). GW1100 also plays the role of a GPR40 inverse agonist. | |||
T14202 | AM-4668 | GPR | |
AM-4668 is a type 2 diabetes GPR40 agonist. For GPR40, in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), the EC50s are 3.6 nM and 36 nM, respectively. | |||
T11459 | GPR40 agonist 1 | Others | |
GPR40 agonist 1 is an effective new GPR40 agonist (EC50s: 17 nM and 2 nM for rGPR40 and hGPR40). | |||
T15267 | GPR40 agonist 4 | Others | |
GPR40 agonist 4 is a potent free fatty acid agonist of receptor 1 (pEC50: 7.54). | |||
T2351L | TAK-875 Hemihydrate | TAK-875,Fasiglifam | GPR |
TAK-875 Hemihydrate (Fasiglifam) is a selective GPR40 agonist with EC50 of 14 nM, 400-fold more potent than oleic acid. | |||
T26868 | BMS-986118 | BMS 986118 | |
BMS-986118 is a full agonist of GPR40, is a G-protein-coupled receptor expressed primarily in pancreatic islets and intestinal L-cells that has been a target of significant recent therapeutic interest for type II diabete... |